Achiko AG Logo

Achiko AG

A digital services platform for cross-border business compliance and engagement.

ACHI | SW

Overview

Corporate Details

ISIN(s):
CH0522213468
LEI:
Country:
Switzerland
Address:
Tessinerplatz 7, 8002 Zürich

Description

Achiko AG operates as a platform for digital services. The company focuses on coordinating compliance and customer engagement for businesses expanding across borders. Its platform also provides content and services across a diverse range of sectors, including technology, lifestyle, and entertainment, with the goal of enhancing user engagement in the digital market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-12-21 06:45
Achiko AG Production and Sales Update
English 13.2 KB
2022-12-21 01:00
Achiko AG Production and Sales Update
English 11.1 KB
2022-12-21 01:00
Achiko AG Produktions- und Vertriebsupdate
German 18.3 KB
2022-12-20 18:00
2022 Ordinary Shareholders Meeting of Achiko AG: Shareholders adopt all proposa…
English 9.6 KB
2022-12-20 01:00
2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders adopt all propos…
English 8.0 KB
2022-12-20 01:00
Ordentliche Generalversammlung 2022 der Achiko AG: Aktionäre nehmen alle Anträg…
German 8.5 KB
2022-11-25 18:10
Achiko AG issues a convocation notice to its shareholders for its Annual Genera…
English 15.9 KB
2022-11-25 01:00
Achiko AG issues a convocation notice to its shareholders for its Annual Genera…
English 14.4 KB
2022-11-25 01:00
Die Achiko AG lädt ihre Aktionäre zur ordentlichen Hauptversammlung am 20. Deze…
German 14.4 KB
2022-11-17 16:10
Achiko AG Announces Corporate Update Webcast
English 16.9 KB
2022-11-17 01:00
Achiko AG Announces Corporate Update Webcast
English 15.1 KB
2022-11-17 01:00
Achiko AG kündigt Webcast zum Unternehmens-Update an
German 15.0 KB
2022-11-16 16:20
Achiko AG Announces Corporate Update Webcast
English 17.0 KB
2022-11-16 01:00
Achiko AG Announces Corporate Update Webcast
English 15.1 KB
2022-11-16 01:00
Achiko AG kündigt Webcast zum Unternehmens-Update an
German 14.9 KB

Automate Your Workflow. Get a real-time feed of all Achiko AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Achiko AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Achiko AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030
Aptahem AB Logo
A clinical-stage biotech developing aptamer-based drugs for life-threatening conditions.
Sweden
APTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.